# Smith & Nephew SNATS Inc. (SNN) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Technology. Price $28.87, market value $12.1 billion.

## Valuation
- **P/E (trailing): 19.6×** (5-yr avg 65.5×, 3-yr avg 60.1×). Smith & Nephew SNATS Inc. trades at 19.6× trailing earnings, well below its own five-year average of 65.5×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 12.0×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.23**. A PEG of 0.23 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.0×**. Each dollar of revenue is priced at 2.0×.
- **Price / book: 11.9×**. The shares trade at 11.9× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Earnings yield: 5.1%**. The inverse of the P/E: 5.1% of the price is earned each year.

## Profitability
- **Gross margin: 68.0%**. Smith & Nephew SNATS Inc. keeps 68.0% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 12.9%**. 12.9% of revenue is left after running the business.
- **Net margin: 10.1%**. 10.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 11.8%**. 11.8% on shareholders' equity is solid.
- **Return on invested capital: 13.0%**. Return on all capital, debt included, is 13.0%.
- **Return on assets: 6.0%**. Each dollar of assets produces 6.0% of profit.

## Growth
- **Revenue growth (1 yr): 6.1%** (3-yr 5.7%/yr, 5-yr 6.2%/yr). Revenue grew 6.1% over the last year, against 6.2% a year compounded over five years.
- **EPS growth (1 yr): 52.3%** (3-yr 41.1%/yr, 5-yr 7.0%/yr). Earnings per share rose 52.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.02**. Debt is 0.02 times equity: a conservative balance sheet.
- **Altman Z-score: 2.95**. A Z-score of 2.95 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 2.75%** ($0.40 per share, trailing). Smith & Nephew SNATS Inc. yields 2.75%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 53%**. 53% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 6**. 6 straight years of increases.
- **Dividend growth (5 yr): 0.3%/yr** (1-yr 1.6%). The dividend has grown 0.3% a year over five years.

## Price and momentum
- **Total return (1 yr): -21.5%** (YTD -10.7%, 3-mo -5.7%). The shares are down 21.5% over twelve months including dividends.
- **From 52-week high: -25.6%** (1.4% above the low). Trading 26% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 42**. An RSI of 42 is neutral.
- **Beta (1 yr): 0.30** (volatility 28%). Beta of 0.30 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SNN · Page: https://foliofundamentals.com/stocks/snn

Not investment advice.